TINRX Mutual Fund

TINRX Mutual Fund

NAV$53.26
See how much of TINRX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Aug 31, 2026

Net Assets
$2.0B
Expense Ratio
0.36%
Dividend Yield (Current)
0.83%
Holdings
2,637
Inception Date
Mar 31, 2006
Fund Family
Nuveen
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+11.08%
1 Year+11.67%
3 Year+22.69%
5 Year+10.69%
10 Year+14.54%

Asset Allocation

Stocks: 99.06%
Bonds: 0.42%
Other: 0.52%
See how much of TINRX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
NVDANVIDIA Corp6.90%
AAPLApple Inc6.14%
MSFTMicrosoft Corp5.05%
AMZNAmazon.com Inc3.38%
GOOGLAlphabet Inc,class A2.65%
Top 10 Concentration: 33.15%Report Date: Aug 31, 2026
Download all 2637 holdings for TINRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.83%
Frequency
Annually
Latest Distribution
$0.62
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

TINRX Mutual Fund Overview

TINRX Mutual Fund (Nuveen Equity Index Fund Class A) is managed by Nuveen with $1.97B in net assets. TINRX expense ratio is 0.36%, holding 2637 positions across sectors including Information Technology, Financials, Consumer Discretionary. Inception date: 2006-03-31.

TINRX performance shows a YTD return of 11.08%. The 1-year return is 11.67% and the 5-year return is 10.69%. TINRX dividend yield stands at 0.83%, paid annually.

TINRX top holdings include NVIDIA Corp (6.9%), Apple Inc (6.1%), Microsoft Corp (5.0%), Amazon.com Inc (3.4%), Alphabet Inc,class A (2.6%). Go to all TINRX holdings, TINRX sectors, or TINRX dividends.

TINRX can be compared against other funds. Use TINRX overlap to find shared positions, or TINRX vs another fund for a side-by-side view. TINRX alternatives are available via the screener, along with tax-loss harvesting opportunities.